
Anand's Case: Why Early Hepatitis B Therapy is Critical in India
The story in brief
Thirty-seven-year-old Anand, an engineer from Begusarai, was hospitalized with liver failure and a tumor caused by undiagnosed hepatitis B, highlighting India's delayed treatment approach. Despite global deaths rising to 1.1 million in 2024, India's NVHCP has criticized for not initiating treatment early, even when viral load is detectable. Over 75% of patients adhere to treatment, yet many face late-stage complications due to asymptomatic infections.